SRD/MRD/IIa
Research payments
$192,579
Through program year 2024, $192,579 in research payments was reported against SRD/MRD/IIa, across 76 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Finland Ky
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $174,741 | 13 |
| 2021 | Research | $17,837 | 63 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Harsha Sen Dothan, AL Named on 10 payments
- Chirag Jhaveri Austin, TX Named on 10 payments
- Caesar Luo Walnut Creek, CA Named on 10 payments
- Joel Pearlman Sacramento, CA Named on 9 payments
- David Brown Houston, TX Named on 8 payments
- Charles Wykoff Houston, TX Named on 7 payments
- Michael Elman Baltimore, MD Named on 6 payments
- Srinivas Sadda Pasadena, CA Named on 5 payments
- Christopher Devine Cincinnati, OH Named on 2 payments
- Quan Nguyen Stanford, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.